ZA201607355B - Group a streptococcus vaccine - Google Patents

Group a streptococcus vaccine

Info

Publication number
ZA201607355B
ZA201607355B ZA2016/07355A ZA201607355A ZA201607355B ZA 201607355 B ZA201607355 B ZA 201607355B ZA 2016/07355 A ZA2016/07355 A ZA 2016/07355A ZA 201607355 A ZA201607355 A ZA 201607355A ZA 201607355 B ZA201607355 B ZA 201607355B
Authority
ZA
South Africa
Prior art keywords
group
streptococcus vaccine
streptococcus
vaccine
Prior art date
Application number
ZA2016/07355A
Other languages
English (en)
Inventor
Manisha Pandey
Michael Batzloff
Michael Good
Original Assignee
Univ Griffith
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2014901382A external-priority patent/AU2014901382A0/en
Application filed by Univ Griffith filed Critical Univ Griffith
Publication of ZA201607355B publication Critical patent/ZA201607355B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1275—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Streptococcus (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/22—Cysteine endopeptidases (3.4.22)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ZA2016/07355A 2014-04-15 2016-10-25 Group a streptococcus vaccine ZA201607355B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AU2014901382A AU2014901382A0 (en) 2014-04-15 Group a streptococcal vaccine
AU2014903042A AU2014903042A0 (en) 2014-08-06 Group a streptococcal vaccine
AU2014904453A AU2014904453A0 (en) 2014-11-05 Group a streptococcal vaccine
PCT/AU2015/050174 WO2015157820A1 (en) 2014-04-15 2015-04-15 Group a streptococcus vaccine

Publications (1)

Publication Number Publication Date
ZA201607355B true ZA201607355B (en) 2019-03-27

Family

ID=54323282

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2016/07355A ZA201607355B (en) 2014-04-15 2016-10-25 Group a streptococcus vaccine

Country Status (16)

Country Link
US (2) US10301362B2 (cg-RX-API-DMAC7.html)
EP (1) EP3131575B1 (cg-RX-API-DMAC7.html)
JP (2) JP2017513849A (cg-RX-API-DMAC7.html)
KR (2) KR102730367B1 (cg-RX-API-DMAC7.html)
CN (1) CN106794236B (cg-RX-API-DMAC7.html)
AU (1) AU2015246654B2 (cg-RX-API-DMAC7.html)
BR (1) BR112016023915B1 (cg-RX-API-DMAC7.html)
CA (1) CA2945052C (cg-RX-API-DMAC7.html)
DK (1) DK3131575T3 (cg-RX-API-DMAC7.html)
IL (1) IL248266B (cg-RX-API-DMAC7.html)
MX (1) MX392514B (cg-RX-API-DMAC7.html)
MY (1) MY191217A (cg-RX-API-DMAC7.html)
NZ (1) NZ725212A (cg-RX-API-DMAC7.html)
SG (1) SG11201608380PA (cg-RX-API-DMAC7.html)
WO (1) WO2015157820A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201607355B (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2945052C (en) 2014-04-15 2023-05-02 Griffith University Group a streptococcus vaccine
CN106606775A (zh) * 2015-10-27 2017-05-03 格里菲斯大学 脂质体a群链球菌疫苗
TWI598360B (zh) * 2016-12-19 2017-09-11 義守大學 Ｆｓｂｍ重組蛋白及其用途
SG11202001557PA (en) * 2017-08-23 2020-03-30 Univ Griffith Immunogenic peptide against group a streptococcus
CN110776508B (zh) * 2018-07-27 2021-07-16 海创药业股份有限公司 一种brd4抑制剂及其制备方法和用途
KR102437436B1 (ko) * 2019-04-26 2022-08-30 주식회사 엠디헬스케어 스트렙토코커스 파이오제네스 세균 유래 단백질 및 이의 용도
NL2023863B1 (en) 2019-09-20 2021-05-25 Univ Griffith Protein particles and uses thereof

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047238A (en) 1983-06-15 1991-09-10 American Home Products Corporation Adjuvants for vaccines
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
US5091513A (en) 1987-05-21 1992-02-25 Creative Biomolecules, Inc. Biosynthetic antibody binding sites
US5811105A (en) 1987-12-23 1998-09-22 Glaxo Wellcome, Inc. Vaccines containing bacteria attenuated by mutations in two genes of the aromatic amino acid biosynthetic pathway
US5785973A (en) 1988-02-01 1998-07-28 Praxis Biologics, Inc. Synthetic peptides representing a T-cell epitope as a carrier molecule for conjugate vaccines
GB8912330D0 (en) 1989-05-30 1989-07-12 Wellcome Found Live vaccines
GB9007194D0 (en) 1990-03-30 1990-05-30 Wellcome Found Live vaccines
AUPM885194A0 (en) * 1994-10-14 1994-11-10 Council Of The Queensland Institute Of Medical Research, The Synthetic peptides and vaccines comprising same
AUPO007396A0 (en) 1996-05-24 1996-06-20 Csl Limited Ebv ctl epitopes
AUPO784197A0 (en) 1997-07-10 1997-08-07 Csl Limited Treatment of nasopharyngeal carcinoma
EP1807446A2 (en) * 2004-10-08 2007-07-18 Novartis Vaccines and Diagnostics, Inc. Immunogenic and therapeutic compositions for streptococcus pyogenes
BRPI0610093A2 (pt) * 2005-05-05 2008-12-09 Merck & Co Inc composiÇço farmacÊutica, e, mÉtodo para prevenir ou tratar uma doenÇa associada com os depàsitos de amilàides de alfa-beta no cÉrebro de um paciente
US8623356B2 (en) 2005-11-29 2014-01-07 The University Of Sydney Demibodies: dimerization-activated therapeutic agents
EP2287189A1 (en) * 2006-07-07 2011-02-23 Intercell AG Small Streptococcus pyogenes antigens and their use
US20090010929A1 (en) * 2006-12-04 2009-01-08 Good Michael F Therapeutic Antibodies, Antibody Fragments and Antibody Conjugates
US8482298B2 (en) 2006-12-18 2013-07-09 Schrader Electronics Ltd. Liquid level and composition sensing systems and methods using EMF wave propagation
JP5653215B2 (ja) * 2007-09-12 2015-01-14 ノバルティス アーゲー Ｇａｓ５７変異体抗原およびｇａｓ５７抗体
US20090162369A1 (en) * 2007-12-12 2009-06-25 Katin Helena Threse Nordstrom Synthetic chimeric peptides
SI2344523T1 (sl) * 2008-09-17 2016-06-30 Glaxosmithkline Biologicals S.A. Kombinirana GAS-cepiva in zdravila
CA2945052C (en) 2014-04-15 2023-05-02 Griffith University Group a streptococcus vaccine
SG11202001557PA (en) * 2017-08-23 2020-03-30 Univ Griffith Immunogenic peptide against group a streptococcus

Also Published As

Publication number Publication date
IL248266B (en) 2021-09-30
IL248266A0 (en) 2016-11-30
NZ725212A (en) 2023-04-28
MX392514B (es) 2025-03-24
US10513544B2 (en) 2019-12-24
CA2945052C (en) 2023-05-02
KR20160144455A (ko) 2016-12-16
EP3131575B1 (en) 2024-05-08
EP3131575A4 (en) 2017-11-01
JP7072921B2 (ja) 2022-05-23
CA2945052A1 (en) 2015-10-22
US10301362B2 (en) 2019-05-28
US20170037087A1 (en) 2017-02-09
CN106794236B (zh) 2021-09-03
KR102744193B1 (ko) 2024-12-19
AU2015246654B2 (en) 2019-08-08
KR20230039751A (ko) 2023-03-21
JP2021042247A (ja) 2021-03-18
MX2016013277A (es) 2017-01-18
BR112016023915B1 (pt) 2024-03-12
MY191217A (en) 2022-06-09
WO2015157820A1 (en) 2015-10-22
SG11201608380PA (en) 2016-11-29
AU2015246654A1 (en) 2016-11-03
DK3131575T3 (da) 2024-05-21
EP3131575A1 (en) 2017-02-22
KR102730367B1 (ko) 2024-11-15
US20190256562A1 (en) 2019-08-22
CN106794236A (zh) 2017-05-31
JP2017513849A (ja) 2017-06-01
BR112016023915A2 (pt) 2017-10-17

Similar Documents

Publication Publication Date Title
GB201410971D0 (en) Vaccine
PL3122672T3 (pl) Chwytak
GB201518684D0 (en) Vaccine
PL3185899T3 (pl) Wzmocniona szczepionka wektorowa-hvt przeciwko nd-ibd
GB201410044D0 (en) A game system
SG11201707926WA (en) Streptococcal vaccine
PL3107946T3 (pl) Poliizomocznik
ZA201607355B (en) Group a streptococcus vaccine
PL3130065T3 (pl) Układ koła zamachowego
IL233295B (en) A control pill dispensing system
GB201522132D0 (en) Vaccine
GB201409688D0 (en) A hanger
GB201616904D0 (en) Vaccine
GB201402247D0 (en) A footgauge
PL3188755T3 (pl) Szczepionka
PT3193923T (pt) Adjuvantes
GB201419061D0 (en) Conjugated Vaccine
GB201614440D0 (en) A furniture system
GB201409666D0 (en) A bat
GB201603029D0 (en) Vaccine
GB201417214D0 (en) Vaccine
GB201406628D0 (en) Vaccine
GB201409512D0 (en) A spacer
GB201402623D0 (en) A hooklink system
AU2014904453A0 (en) Group a streptococcal vaccine